Skip to content
★ Sign in to follow
팜스

팜스빌 Stock: price and insider trades · South Korea

KR·Mcap ₩27.2BHealth Care

No insider purchase over the last 90 days. The latest, by 신완균, was filed 30 Jan 2026.

팜스빌: what insiders have been doing

This page follows insider dealings at 팜스빌 as filed with DART (FSS), a company from the Health Care sector. 1 insider has disclosed 1 filing since 10 November 2025.

Every open-market trade in the period is a purchase: 1 purchase, from 1 insider, and not a single sale. No amount is published for 1 filing, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. On the buying side, the filings list 1 board member among the declarants.

The latest purchase dates back some time: it was published 284 days ago, on 30 January 2026.

For context, the typical company on the same exchange (median of 2,648 companies) published 7 filings over the same period, against 1 filing here. Looking back to 2023, when coverage begins, insiders filed 2 purchases and 2 sales.

Elsewhere in the same sector, our signals recently picked up insider purchases at Cooper Companies, Inc. and Cytosorbents Corp. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.

Insider Decl.
7
Thresholds
n/a
Buy Volume
n/a
2 ops. · all time
Sell Volume
n/a
2 ops. · all time

Who traded when

BuySale
이병욱2 sales
신완균1 buy
헬스클릭1 buy
Fundamental score
Ranked 1,400 of 26,911 companies
78.7
score / 100
Value
79
Quality
78
FCF yld6.7%
Earn yld11%
EV/EBITDA6.4x
ROE4.6%
Gross mgn63%
Net mgn23%
Debt/EBITDA0.0x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩3,525
Analyst consensus
·
Income statement
Revenue₩12.7B
Gross profit₩8.1B63% margin
EBITDA₩4.2B33% margin
Net income₩2.9B26.7% margin
Valuation
Beta0.15
Balance sheet & cash
Market cap₩27.2B
Total debt₩16.5M
Free Cash Flow₩1.8B
Debt / Equity0%
Profitability & ownership
ROE4.6%
ROA-0.6%
% insiders75.7%
% institutions0.0%
Last declaration on 30 January 2026
Declarations7 total
  • ▲
    Executives(filed)
    0DART
    1,900 sharesShareKRXDART:20260130000121
    Canonical exit: 30 Apr 2026 (T+90)
  • ▲
    Executives(filed)
    0DART
    862,896 sharesShareKRXDART:20250502000301
    Canonical exit: 31 Jul 2025 (T+90)
  • ▼
    대량보유자Executives
    0DART
    555,156 sharesKRXDART:20250502000338
  • ▼
    Executives(filed)
    0DART
    800,000 sharesShareKRXDART:20250502000292
  • ●
    대표이사Executives
    0DART
    ShareKRXDART:20230920000123
  • ●
    대표이사Executives
    0DART
    ShareKRXDART:20230522000306
  • ●
    대표이사Executives
    0DART
    ShareKRXDART:20230504000811

7 of 7 declarations

About 팜스빌

팜스빌 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in the development and marketing of pharmaceutical products.